Canadian Strategy for Cancer Control (2019-2029)
The refreshed Canadian Strategy for Cancer Control is here. Based on input from more than 7,500 Canadians including healthcare leaders from across the country, the Strategy sets the course for a more equitable approach to cancer in Canada. No matter who we are or where we live, we should all have access to world-class cancer care for generations to come.
Discover more about the modernized Canadian Strategy for Cancer Control. Visit cancerstrategy.ca.
CCRA Exceptional Leadership in Cancer Research Award to be Renamed
Effective October 9, 2024, the CCRA Advisory Board voted to modify the Exceptional Leadership in Cancer Research to the “Philip E. Branton Award for Exceptional Leadership in Cancer Research” to acknowledge and recognize Dr. Branton’s pivotal role in the creation of CCRA and his extraordinary contribution to Canada’s cancer research community. Dr. Branton was the inaugural recipient of this award when the program was initiated in 2011.
Dr. Branton obtained his PhD from the Ontario Cancer I... Read More »
Canada’s Drug Agency (CDA-AMC)
In December 2023, it was announced that Canada’s Drug Agency would be built from CADTH. The work of the drug agency expands on CADTH’s existing mandate and functions — which spans drugs, medical devices, and c... Read More »
In December 2023, it was announced that Canada’s Drug Agency would be built from CADTH. The work of the drug agency expands on CADTH’s existing mandate and functions — which spans drugs, medical devices, and c... Read More »